LAHORE: The Pharma Bureau representatives have expressed reservations over the new drug pricing policy proposed by the Policy Board of the Drug Regulatory Authority of Pakistan (DRAP).
The DRAP had proposed 30 per cent cut on the life-saving and other drugs.
The Pharma Bureau, which is research-based multinational pharmaceutical companies, urged the government, Finance Minister Senator Ishaq Dar and State Minister Saira Afzal Tarar to avert a potential drug crisis by formulating a committee to review the draft drug pricing policy.
On the other hand, Pakistan Young Pharmacists Association welcomed the DRAP’s decision saying that it would help improve health status of the patients.
Pakistan’s annual inflation eases to 11.1pc in June, says PBS
ISLAMABAD: Pakistan’s annual inflation eased to 11.1 per cent in June from 11.7 per cent in May, while prices declined...
